Treatment of synchronous uterine and ovarian cancer

The treatment of synchronous uterine and ovarian cancer is devoted to a small number of publications, usually based on single clinical observations. Since synchronous tumors are considered as metastatic, indicating a widespread tumor process, most researchers are supporters of complex treatment consisting of surgical intervention combined with radiation and drug therapy. Meanwhile, there are other points of view. For example, the question about the advisability of including chemotherapy in the plan of complex treatment remains open, since it is still unclear whether it contributes to a better survival rate of patients. Some authors believe that if a diagnosis of early primary multiple cancer is made, only surgery followed by hormone therapy or without it is sufficient.